Year : 2015 | Volume
: 17 | Issue : 2 | Page : 269--273
Urokinase-type plasminogen activator: a new target for male contraception?
Ying Qin, Yan Han, Cheng-Liang Xiong, Hong-Gang Li, Lian Hu, Ling Zhang
Family Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Urokinase-type plasminogen activator (uPA) is closely related to male reproduction. With the aim of investigating the possibility for uPA as a potential contraceptive target, in the present work, Kunming male mice were immunized by human uPA subcutaneous injection at three separate doses for 3 times. Then the potency of the anti-human uPA antibody in serum was analyzed, and mouse fertility was evaluated. Serum antibody titers for human uPA in immunized groups all reached 1:10,240 or higher levels by enzyme linked immunosorbent assay, and mating experiments revealed that pregnancy rates and the mean number of embryos implanted after mating declined obviously (P < 0.05) when compared with control groups. However, the mating capacity and reproductive organ weights had no obvious change, and histological analysis of the testes and epididymides also showed normal morphology for immunized male mice. Sperm function tests suggested that the sperm concentration, sperm viability, sperm motility, and in vitro fertilization rate for the cauda epididymis sperm in uPA-immunized groups were lower than those in the controls (P < 0.05). Together, these observations indicated that subcutaneous injection human uPA to the male mice could effectively reduce their fertility, and uPA could become a new target for immunocontraception in male contraceptive development.
Family Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
|How to cite this article:|
Qin Y, Han Y, Xiong CL, Li HG, Hu L, Zhang L. Urokinase-type plasminogen activator: a new target for male contraception?.Asian J Androl 2015;17:269-273
|How to cite this URL:|
Qin Y, Han Y, Xiong CL, Li HG, Hu L, Zhang L. Urokinase-type plasminogen activator: a new target for male contraception?. Asian J Androl [serial online] 2015 [cited 2020 Aug 9 ];17:269-273
Available from: http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=2;spage=269;epage=273;aulast=Qin;type=0